Journal article
Cancer, chitosan nanopartides and catalytic nucleic acids
ML Tan, PFM Choong, CR Dass
Journal of Pharmacy and Pharmacology | Published : 2009
Abstract
Objectives The aim of this review was to examine gene therapy involving DNAzyme and siRNA encapsulation into chitosan nanoparticles, discussing the current and future status of this drug delivery system in enhancing drug delivery and cancer therapy. Key findings Cancer is a disease state in which the cells in our body undergo mutations at the genetic level and are transformed, acquiring the ability to replicate limitlessly. Conventional cancer treatment involves the use of surgery and cytotoxic chemotherapy and/or radiotherapy, which have the potential of harming normal, otherwise healthy, nonneoplastic cells. Newer forms of therapy such as immunotherapy and gene therapy have shown initial p..
View full abstractGrants
Funding Acknowledgements
We thank the Australian Orthopaedics Association and the Victorian Orthopaedic Research Trust Grant for financial support.